Aptevo Therapeutics Inc. (APVO) financial statements and ratios from SEC XBRL: revenue $3.11M (TTM), net margin 257.8%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.11M |
| Net Margin | 257.8% |
| Return on Equity | -437.1% |
| Current Ratio | 2.08 |
| Price / Book | 0.80 |
| Sector P/E (Healthcare) | 21.7 |
APVO overview · APVO earnings · APVO KPIs · APVO investor relations · APVO ownership · APVO peers · APVO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.